Phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a comparison of safety profiles. - Wikidata - awgldk - TriplyDB

Phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a comparison of safety profiles.

Phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a comparison of safety profiles.

http://www.wikidata.org/entity/Q38202179

about

Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide Vascular calcification: When should we interfere in chronic kidney disease patients and how?Stop chronic kidney disease progression: Time is approaching Hyperphosphatemia as an independent risk factor for coronary artery calcification progression in peritoneal dialysis patients.Comparative Effectiveness of Phosphate Binders in Patients with Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis.Effects of different phosphate lowering strategies in patients with CKD on laboratory outcomes: A systematic review and NMA.Economic evaluations of interventions to manage hyperphosphataemia in adult haemodialysis patients: A systematic review.The efficacy and safety of sevelamer and lanthanum versus calcium-containing and iron-based binders in treating hyperphosphatemia in patients with chronic kidney disease: a systematic review and meta-analysis.Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.Is It Too Much of a Good Thing? A New Era in Phosphate Binder Therapy in ESRD.The future of phosphate binders: a perspective on novel therapeutics.Adherence rates to ferric citrate as compared to active control in patients with end stage kidney disease on dialysis.

P2860

Q26764806-6D976EA1-3BE2-48D3-8462-E43A86F57EF9 Q28071582-E111E915-C420-4F20-9B74-F12BA930D991 Q28078020-0618C470-C98D-44BF-BFF9-1BB394BF4794 Q35695757-29856590-6DD1-4585-B116-4EB1AA817CE6 Q36045060-B16B241E-6C7A-4005-8C4B-730F0BC551A0 Q36293813-304CDAD6-4F8B-4A5F-AD58-BCEC4965FCC0 Q38561447-72038EBE-BD47-4F65-BA21-5E0747C00B57 Q38819231-8C6B4423-BB6E-49FE-9A2B-6F78FCC225C7 Q38828902-6ADF8E8F-1CF4-4607-9C9A-2F4E1C6EC121 Q43236775-2E316C58-F43F-4087-8E9A-39899A04EB50 Q44090122-6737D806-1AAA-44B6-8216-A56071B793BE Q53775627-65CE00A2-7DC4-4284-9DED-E6C2C3699BD1

P2860

Phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a comparison of safety profiles.

http://www.wikidata.org/entity/Q38202179

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Phosphate binders for the trea ...... comparison of safety profiles.

@en

type

label

Phosphate binders for the trea ...... comparison of safety profiles.

@en

prefLabel

Phosphate binders for the trea ...... comparison of safety profiles.

@en

P1433

Q38202179-9D1FD6F1-ED5B-49DB-A3E4-4388B89CAD2D

P1476

Q38202179-4162CA50-DC81-470D-A470-0B0A67044AB2

P2093

Q38202179-3760B043-4D12-437E-89C9-6FBBBA3DE294

Q38202179-3FBF044D-1F2B-40D0-8264-6B415332AFC7

Q38202179-552E9897-8934-482F-BD8F-86E531B9350E

Q38202179-7CB94042-5F21-4446-BA40-CACE146F979F

P2860

Q38202179-00321B84-18B9-4B03-8CE1-D633B01F4182

Q38202179-0069CF3E-532E-4D3C-ACAD-314D4AF513D2

Q38202179-01D55D33-31CC-4950-BFC8-780CC4EB8856

Q38202179-035E5A8B-0D1B-4A88-9105-B26AF5DEE626

Q38202179-0847302C-1BFD-4F8E-B00A-C555DD6BCD55

Q38202179-1260E00C-1D2A-49B7-A2AC-E08BC682D460

Q38202179-1A2AD187-4213-4062-95EB-BD3AA490C596

Q38202179-282D05A9-F847-4E79-B8E2-48B091DBB9E4

Q38202179-283B53C9-7E95-490A-849A-378C05BAF5B3

Q38202179-2869C3B0-1CF3-4A35-BCF8-2B8D8D74435E

P304

Q38202179-2315EA04-8C9D-402C-865B-DF846883852B

P31

Q38202179-9A4BB8E6-8868-433F-8FF7-F8FA0BD8CC44

P356

Q38202179-BE08019B-2C16-486B-AED3-D2BE5929012B

P407

Q38202179-D41FE5A9-ED20-43C4-B42D-7FA43F2345A1

P433

Q38202179-99EAAE2A-345F-41F3-A5F4-E9AA62BF0D36

P478

Q38202179-C04B5E72-8D76-4849-BBC6-663AC590EEED

P577

Q38202179-162FE5AC-C541-460B-A376-B42ADD1A9522

P698

Q38202179-350A74FB-D4FD-45AF-A1BE-FC6CA1E8B1EF

P921

Q38202179-9A71F847-C07F-413A-B8B5-10D57075CD02

P356

14740338.2014.907791

P1433

Expert Opinion on Drug Safety

P1476

Phosphate binders for the trea ...... comparison of safety profiles.

@en

P2093

Francesco Locatelli

http://www.w3.org/2001/XMLSchema#string

Giuseppe Pontoriero

http://www.w3.org/2001/XMLSchema#string

Leano Violo

http://www.w3.org/2001/XMLSchema#string

Lucia Del Vecchio

http://www.w3.org/2001/XMLSchema#string

P2860

Oral phosphate binders in patients with kidney failure

A model of the kinetics of lanthanum in human bone, using data collected during the clinical development of the phosphate binder lanthanum carbonate.

Sevelamer hydrochloride (Renagel), a nonabsorbed phosphate-binding polymer, does not interfere with digoxin or warfarin pharmacokinetics.

The emerging role of phosphate in vascular calcification.

Digoxin, hypercalcaemia, and cardiac conduction.

Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability

Pharmacology, efficacy and safety of oral phosphate binders.

Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study.

Comparative effectiveness of calcium-containing phosphate binders in incident U.S. dialysis patients

Aluminium and bone disease in chronic renal failure.

P304

551-561

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14740338.2014.907791

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24702470

http://www.w3.org/2001/XMLSchema#string

P921